vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

Creative Media & Community Trust Corp is the larger business by last-quarter revenue ($28.5M vs $26.6M, roughly 1.1× NeuroPace Inc). NeuroPace Inc runs the higher net margin — -10.3% vs -125.8%, a 115.5% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 3.6%). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

CMCT vs NPCE — Head-to-Head

Bigger by revenue
CMCT
CMCT
1.1× larger
CMCT
$28.5M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+20.2% gap
NPCE
23.9%
3.6%
CMCT
Higher net margin
NPCE
NPCE
115.5% more per $
NPCE
-10.3%
-125.8%
CMCT
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
NPCE
NPCE
Revenue
$28.5M
$26.6M
Net Profit
$-11.4M
$-2.7M
Gross Margin
77.4%
Operating Margin
-125.6%
-6.6%
Net Margin
-125.8%
-10.3%
Revenue YoY
3.6%
23.9%
Net Profit YoY
-11.4%
48.0%
EPS (diluted)
$-3.89
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
NPCE
NPCE
Q4 25
$28.5M
$26.6M
Q3 25
$26.2M
$27.4M
Q2 25
$29.7M
$23.5M
Q1 25
$32.3M
$22.5M
Q4 24
$27.5M
$21.5M
Q3 24
$28.6M
$21.1M
Q2 24
$34.4M
$19.3M
Q1 24
$34.0M
$18.1M
Net Profit
CMCT
CMCT
NPCE
NPCE
Q4 25
$-11.4M
$-2.7M
Q3 25
$-12.5M
$-3.5M
Q2 25
$-9.0M
$-8.7M
Q1 25
$-6.1M
$-6.6M
Q4 24
$-10.3M
$-5.3M
Q3 24
$-10.4M
$-5.5M
Q2 24
$-796.0K
$-7.5M
Q1 24
$-3.7M
$-8.9M
Gross Margin
CMCT
CMCT
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
CMCT
CMCT
NPCE
NPCE
Q4 25
-125.6%
-6.6%
Q3 25
-47.7%
-9.5%
Q2 25
-30.3%
-29.0%
Q1 25
-19.0%
-22.9%
Q4 24
-128.8%
-17.0%
Q3 24
-36.9%
-20.1%
Q2 24
-1.6%
-32.4%
Q1 24
-10.7%
-41.6%
Net Margin
CMCT
CMCT
NPCE
NPCE
Q4 25
-125.8%
-10.3%
Q3 25
-47.5%
-12.8%
Q2 25
-30.3%
-36.8%
Q1 25
-18.9%
-29.3%
Q4 24
-129.8%
-24.5%
Q3 24
-36.3%
-25.9%
Q2 24
-2.3%
-39.0%
Q1 24
-11.0%
-49.2%
EPS (diluted)
CMCT
CMCT
NPCE
NPCE
Q4 25
$-3.89
$-0.08
Q3 25
$-23.52
$-0.11
Q2 25
$-18.94
$-0.26
Q1 25
$-20.73
$-0.21
Q4 24
$97.71
$-0.16
Q3 24
$-305.04
$-0.19
Q2 24
$-98.64
$-0.26
Q1 24
$-125.46
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$15.4M
$61.1M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$19.0M
Total Assets
$859.2M
$105.6M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
NPCE
NPCE
Q4 25
$15.4M
$61.1M
Q3 25
$17.3M
$60.0M
Q2 25
$27.8M
$62.1M
Q1 25
$19.8M
$66.3M
Q4 24
$20.3M
$52.8M
Q3 24
$18.5M
$56.8M
Q2 24
$29.3M
$55.5M
Q1 24
$21.3M
$58.9M
Total Debt
CMCT
CMCT
NPCE
NPCE
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
NPCE
NPCE
Q4 25
$265.4M
$19.0M
Q3 25
$281.9M
$18.5M
Q2 25
$287.1M
$19.4M
Q1 25
$293.0M
$24.3M
Q4 24
$304.5M
$8.0M
Q3 24
$321.0M
$9.8M
Q2 24
$351.1M
$9.9M
Q1 24
$369.9M
$14.3M
Total Assets
CMCT
CMCT
NPCE
NPCE
Q4 25
$859.2M
$105.6M
Q3 25
$871.8M
$107.3M
Q2 25
$885.0M
$106.1M
Q1 25
$882.3M
$110.2M
Q4 24
$889.6M
$94.6M
Q3 24
$868.0M
$96.3M
Q2 24
$891.2M
$94.4M
Q1 24
$887.5M
$98.9M
Debt / Equity
CMCT
CMCT
NPCE
NPCE
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
NPCE
NPCE
Operating Cash FlowLast quarter
$5.8M
$506.0K
Free Cash FlowOCF − Capex
$409.0K
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
NPCE
NPCE
Q4 25
$5.8M
$506.0K
Q3 25
$3.7M
$-1.9M
Q2 25
$-2.5M
$-2.1M
Q1 25
$1.2M
$-7.5M
Q4 24
$17.0M
$-4.8M
Q3 24
$10.3M
$-1.7M
Q2 24
$3.9M
$-3.9M
Q1 24
$1.6M
$-7.5M
Free Cash Flow
CMCT
CMCT
NPCE
NPCE
Q4 25
$409.0K
Q3 25
$-2.0M
Q2 25
$-2.3M
Q1 25
$-7.5M
Q4 24
$-4.8M
Q3 24
$-1.8M
Q2 24
$-4.0M
Q1 24
$-7.6M
FCF Margin
CMCT
CMCT
NPCE
NPCE
Q4 25
1.5%
Q3 25
-7.2%
Q2 25
-9.6%
Q1 25
-33.4%
Q4 24
-22.5%
Q3 24
-8.7%
Q2 24
-20.6%
Q1 24
-42.1%
Capex Intensity
CMCT
CMCT
NPCE
NPCE
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.5%
Q2 24
0.3%
Q1 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons